HarrisMartin’s Allergan Breast Implant Associated Anaplastic Large Cell Lymphoma Litigation Conference

9:30 a.m. - 10:00 a.m.

Registration

10:00 a.m. - 10:15 a.m.

Welcome By Co-Chairs

Mark P. Robinson Jr., Robinson Calcagnie, Inc., Newport Beach, CA
Jennifer Lenze, Lenze Lawyers, PLC, Manhattan Beach, CA

10:15 a.m. - 10:45 a.m.

History of Allergan

Mark P. Robinson Jr., Robinson Calcagnie, Inc., Newport Beach, CA

10:45 a.m. - 11:15 a.m.

Allergan Natrelle BIOCELL Textured Implants and the Link to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Jennifer Lenze, Lenze Lawyers, PLC, Manhattan Beach, CA

11:15 a.m. - 11:30 a.m.

Regulatory Actions

Dena Young, Ross Feller Casey, LLP, Philadelphia

11:30 a.m. - 11:45 a.m.

Review of the Medical Literature

Greg Sonstein, Panish Shea & Boyle LLP, Los Angeles

11:45 a.m. - 12:00 p.m.

Preemption

Moze Cowper, Cowper Law LLP, Los Angeles

12:00 p.m. - 1:15 p.m.

Lunch

Lunch Sponsored by Robinson Calcagnie, Inc..

1:15 p.m. - 1:45 p.m.

Jurisdiction and the Coordination Petition

Dena Sharp, Girard Sharp, San Francisco
Elizabeth Kramer, Girard Sharp, San Francisco

1:45 p.m. - 2:30 p.m.

Complaint Handling and Medical Device Reports (MDRs)

Wyatt Vespermann, Bentley & More LLP, Newport Beach, CA
Madris Tomes, MBA, CEO, Device Events, York, PA

2:30 p.m. - 3:00 p.m.

Diagnosing BIA-ALCL

Dennis P. O’Malley, M.D., Hematopathologist, Clarient Diagnostic Services (a NeoGenomics Company), Aliso Viejo, CA